Total Payments
$408.12
2024 Payments
$340.88
Companies
7
Transactions
22
Medicare Patients
1,503
Medicare Billing
$201,170
Payment Breakdown by Category
Food & Beverage$408.12 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $408.12 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $191.12 | 11 | $0 (2024) |
| Lilly USA, LLC | $118.22 | 6 | $0 (2024) |
| ABBVIE INC. | $24.99 | 1 | $0 (2024) |
| Kyowa Kirin, Inc. | $21.44 | 1 | $0 (2024) |
| PFIZER INC. | $19.56 | 1 | $0 (2024) |
| Eisai Inc. | $19.14 | 1 | $0 (2021) |
| Exact Sciences Corporation | $13.65 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $340.88 | 18 | Novo Nordisk Inc ($179.92) |
| 2023 | $36.90 | 2 | Lilly USA, LLC ($36.90) |
| 2021 | $30.34 | 2 | Eisai Inc. ($19.14) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.10 | General |
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.18 | General |
| 10/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Obesity | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Obesity | ||||||
| 04/25/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $17.64 | General |
| 04/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: VACCINES | ||||||
| 03/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Oncology | ||||||
| 02/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Obesity | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 01/16/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 01/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Obesity | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 09/07/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Diabetes | ||||||
| 09/02/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 752 | 1,951 | $257,894 | $112,184 |
| 2022 | 16 | 751 | 1,260 | $186,748 | $88,986 |
Total Patients
1,503
Total Services
3,211
Medicare Billing
$201,170
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 212 | 951 | $164,188 | $70,964 | 43.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 135 | 363 | $30,436 | $14,389 | 47.3% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 52 | 66 | $16,485 | $7,297 | 44.3% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 89 | 202 | $12,896 | $6,076 | 47.1% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 77 | 123 | $12,741 | $4,968 | 39.0% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 74 | 115 | $7,016 | $2,793 | 39.8% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 33 | 33 | $6,603 | $2,524 | 38.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 57 | 70 | $4,880 | $2,143 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,716 | $636.13 | 37.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 17 | $933.00 | $394.80 | 42.3% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 162 | 435 | $79,883 | $37,904 | 47.4% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 69 | 104 | $27,309 | $12,988 | 47.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 61 | 134 | $12,462 | $5,935 | 47.6% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 58 | 76 | $9,865 | $4,683 | 47.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 43 | 61 | $7,503 | $3,562 | 47.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 66 | 78 | $6,739 | $3,207 | 47.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 41 | 70 | $6,510 | $3,101 | 47.6% |
| 99349 | Established patient home visit, typically 40 minutes | Office | 2022 | 22 | 36 | $6,300 | $2,997 | 47.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 23 | 23 | $5,244 | $2,730 | 52.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 24 | 29 | $3,567 | $1,694 | 47.5% |
| 99350 | Established patient home visit, typically 1 hour | Office | 2022 | 12 | 14 | $3,388 | $1,614 | 47.7% |
| 99328 | New patient custodial care facility, group care, or assisted living visit, typically 75 minutes | Office | 2022 | 11 | 11 | $3,264 | $1,547 | 47.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 30 | 42 | $2,730 | $1,303 | 47.7% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 26 | 26 | $2,548 | $1,212 | 47.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 14 | 14 | $2,436 | $1,161 | 47.7% |
About Joevelino Raymundo, NP-C
Joevelino Raymundo, NP-C is a Nurse Practitioner healthcare provider based in Zebulon, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2021. The National Provider Identifier (NPI) number assigned to this provider is 1700461662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joevelino Raymundo, NP-C has received a total of $408.12 in payments from pharmaceutical and medical device companies, with $340.88 received in 2024. These payments were reported across 22 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($408.12).
As a Medicare-enrolled provider, Raymundo has provided services to 1,503 Medicare beneficiaries, totaling 3,211 services with total Medicare billing of $201,170. Data is available for 2 years (2022–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Zebulon, NC
- Active Since 03/12/2021
- Last Updated 09/26/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1700461662
Products in Payments
- MOUNJARO (Drug) $75.20
- Ozempic (Drug) $60.47
- Wegovy (Drug) $59.96
- JARDIANCE (Drug) $25.38
- VRAYLAR (Drug) $24.99
- Rybelsus (Drug) $23.41
- Crysvita (Drug) $21.44
- PREVNAR 20 (Biological) $19.56
- Dayvigo (Drug) $19.14
- Cologuard Collection Kit (Device) $13.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.